published Jul 10th 2017, 5:18 pm, by Anna Edney (Bloomberg) —Congress must renew a fee program that funds government review of new drugs and medical devices, but a legislative logjam over the Senate’s health-care overhaul stands in its way. Lawmakers need to sign off on the drug and device fees

©2015 Bloomberg News NP7TSVSYF01T (Bloomberg) — Hedge funds accumulated the most bearish bet ever on crops from corn to soybeans after a mix of sunshine and rain created almost perfect growing conditions for U.S. farms. Across the Midwest, the weather’s been dry enough to get fieldwork done, with enough showers